<DOC>
	<DOCNO>NCT02020512</DOCNO>
	<brief_summary>This study evaluate 0.03 % bimatoprost treatment primary open angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>A Study 0.03 % Bimatoprost Treatment Primary Open Angle Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<criteria>Diagnosis openangle glaucoma ocular hypertension No use LumiganÂ® past 3 month Received laser therapy , glaucoma surgery , cataract surgery , ocular surgery within past 3 month</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>